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ABSTRACT Quercetin, a bioflavonoid, is known to affect Ca2 fluxes in sarcoplasmic reticulum, although its direct effect on
Ca2 release channel (CRC) in sarcoplasmic reticulum has remained to be elucidated. The present study examined the effect
of quercetin on the behavior of single skeletal CRC in planar lipid bilayer. The effect of caffeine was also studied for
comparison. At very low [Ca2]cis (80 pM), quercetin activated CRC marginally, whereas at elevated [Ca
2]cis (10 M), both
open probability (Po) and sensitivity to the drug increased markedly. Caffeine showed a similar tendency. Analysis of lifetimes
for single CRC showed that quercetin and caffeine led to different mean open-time and closed-time constants and their
proportions. Addition of 10 M ryanodine to CRC activated by quercetin or caffeine led to the typical subconductance state
(54%) and a subsequent addition of 5 M ruthenium red completely blocked CRC activity. When 6 M quercetin and 3 mM
caffeine were added together to the cis side of CRC, a time-dependent increase of Po was observed (from mode 1 (0.376 
0.043, n  5) to mode 2 (0.854  0.062, n  5)). On the other hand, no further activation was observed when quercetin was
added after caffeine. Quercetin affected only the ascending phase of the bell-shaped Ca2 activation/inactivation curve,
whereas caffeine affected both ascending and descending phases. [3H]ryanodine binding to sarcoplasmic reticulum showed
that channel activity increased more by both quercetin and caffeine than by caffeine alone. These characteristic differences
in the modes of activation of CRC by quercetin and caffeine suggest that the channel activation mechanisms and presumably
the binding sites on CRC are different for the two drugs.
INTRODUCTION
The generally accepted view concerning the mechanism of
excitation-contraction coupling of mammalian skeletal mus-
cle is that excitation, initiated at the cell surface by an action
potential, is propagated into the cell through transverse
tubule (Ebashi and Endo, 1968; Bers, 1991). Consecutively,
the L-type Ca2 channel/dihydropyridine receptor located
in the transverse tubule activates by mechanical coupling
the sarcoplasmic reticulum (SR) Ca2 release channel
(CRC)/ryanodine receptor (Endo et al., 1977; Rios and
Pizarro, 1991; Meissner, 1994). The native ryanodine re-
ceptor complex is composed of homotetramers, which are
associated with FKBP12 in 1:1 molar ratio.
Caffeine, a 1,3,7-trimethylxanthine, is one of the most
widely used exogenous activators of the CRC (Rousseau et
al., 1988, 1989; Sitsapesan et al., 1990; Hernandez-Cruz et
al., 1995; Meissner et al., 1997). In both skeletal and cardiac
muscles, caffeine increases channel open probability (Po)
without a change of channel conductance. Caffeine (0.5–2
mM) increases the apparent affinity of the channel activator
Ca2 and increases Po due to a reduced lifetime of the
closed state (Rousseau et al., 1988; Sitsapesan et al., 1990).
Channel activation by low millimolar caffeine requires the
presence of submicromolar Ca2. However, at higher than 5
mM, caffeine can activate the channel also at picomolar
Ca2 by increasing the lifetime of the open channel, which
is associated with the appearance of an additional long-lived
open state (Sitsapesan et al., 1990). Channels activated by
caffeine are characteristically modified by ryanodine, ATP,
Mg2, and ruthenium red (Rousseau et al., 1989; Sitsapesan
et al., 1990).
Flavonoids are common constituents of higher plants,
with extensive medical uses. According to the review by
Formica and Regelson (1995), flavonoids are broad modu-
lators of antioxidants and inhibitors of ubiquitous enzymes
(e.g., ornithine carboxylase and protein kinase) (Gschwendt
et al., 1983; Nishino et al., 1984; Bindoli et al., 1985; Robak
and Gryglewski, 1988; Fewtrell and Gomperts, 1977). They
also promote vasodilatation and platelet disaggregation
(Harborne, 1967; Beretz et al., 1982). Quercetin
(3,3,4,5,7-pentahydroxyflavone), a bioflavonoid, is widely
distributed in rinds, barks, clover blossoms, and ragweed
pollen. Quercetin inhibits the activities of various ATPases
such as Ca2-ATPase in SR (Deters et al., 1975; Kuriki and
Racker, 1976; Berton et al., 1980; Shoshan et al., 1980,
1981; Havsteen, 1983; Bull et al., 1989; Fewtrell and
Gomperts, 1977). Shoshan et al. (1980) reported that quer-
cetin reversibly inhibited Ca2-ATPase activity and Ca2
uptake of skeletal SR and caused a slow increase in tension
in a skinned fiber loaded with Ca2.
On the other hand, Kirino and Shimizu (1982) reported
that quercetin stimulated Ca2 release from fragmented SR
in the absence of extravesicular Ca2, although they did not
provide any direct evidence for a specific Ca2 efflux
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pathway. Watras et al. (1983) demonstrated that quercetin
increased Ca2 release from skeletal SR in the presence of
50 mM inorganic phosphate. Palade et al. (1983) also
showed an enhancement of spontaneous Ca2 release from
SR by quercetin when the SR was loaded in the presence of
100 mM inorganic phosphate. Kim et al. (1983) first re-
ported that quercetin caused caffeine-like Ca2 release from
fragmented rabbit skeletal SR. However, the effect of quer-
cetin on single CRC remains to be investigated.
In this work, we have studied the effects of quercetin on
the single channel behavior of the skeletal muscle CRC
using the planar lipid bilayer method. For comparison, the
effects of caffeine on single CRCs were also determined.
The results show that both quercetin and caffeine activate
CRC at the single channel level. However, major differ-
ences in the modes of channel activation suggest that quer-
cetin and caffeine activate the skeletal muscle CRC by two
different mechanisms.
MATERIALS AND METHODS
Isolation of SR vesicles
A heavy fraction of fragmented SR vesicles representing
junctional SR was prepared from rabbit fast twitch back and
leg muscles using the procedure of Kim et al. (1983).
Planar lipid bilayer method
Single channel recordings of rabbit skeletal CRC incorpo-
rated into planar lipid bilayers were carried out as described
previously (Miller et al., 1976; Smith et al., 1986; Oba et al.,
1996). Lipid bilayers consisting of brain phosphatidyleth-
anolamine and phosphatidylserine (1:1) in decane (20 mg/
ml) were formed across a hole of 200-m diameter.
Thinning of the bilayer film was monitored by bilayer
capacitance. The basic composition of cis/trans solution
was 1 M KCl, 109 M CaCl2, 100 M EGTA ([Ca
2]free
10 M), and 10 mM K-HEPES, pH 7.3 (Meissner et al.,
1997). After bilayer formation, SR vesicles (1–10 g/ml)
were added to the cis side and gently stirred. Incorporation
of ion channels was achieved as described by Miller and
Racker (1976). The incorporation of CRCs into the bilayer
was confirmed by recording the characteristically high sin-
gle channel-conductance of the CRCs (Meissner, 1994; see
also Fig. 3 D). More than 7 of 10 experiments showed the
incorporation of a single or multiple CRCs. Multichannel
recordings with SR potassium and chloride channels distin-
guishable in terms of their much smaller conductance than
CRCs were disregarded.
The channel was incorporated in a fixed orientation into
the bilayer, as checked by its sensitivity to cis ATP (Meiss-
ner, 1994). The cis side of the bilayer corresponded to the
cytoplasmic side of the SR membrane, whereas the luminal
side of the SR membrane corresponded to the trans side.
Accordingly all effectors were applied to the cis side. The
trans chamber was held at ground and the cis chamber was
clamped at 30 mV relative to the ground using a bridge
made of 2% agar in 200 mM KCl and Ag/AgCl electrodes.
The effects of quercetin, caffeine, ryanodine, ruthenium red,
K-ATP, GSSG, and GSH on channel activity were tested by
adding aliquots of each stock solution (100 mM caffeine, 10
mM ryanodine, 1 mM ruthenium red, 0.5 M K-ATP, 0.5 M
GSSG, and 1 M GSH in water, and 20 or 50 mM quercetin
in ethanol) to the cis chamber. For quercetin experiments, a
freshly prepared quercetin stock solution was used each
time, because precipitation could occur during storage pe-
riod. Solubility of quercetin in aqueous solutions was con-
firmed by observation of the apparent molar extinction
coefficient (  562.341 cm2/mol at 258). The experiments
were carried out at 18 to 23°C.
Solutions with different free Ca2 concentrations were
prepared by varying the ratio of [EGTA] and [CaCl2] using
the stability constant according to Martell and Smith (1974).
Free Ca2 concentrations below 10 M were obtained by
adding 50 mM EGTA aliquots to a solution that contained
109 M CaCl2. Free Ca
2 concentrations above 10 M
Ca2 were obtained by adding 50 mM or 1 M CaCl2
aliquots to a solution that contained 100 M EGTA. Free
[Ca2]  10 M were confirmed with a Ca2 electrode
(Orion Research Inc.) and using serial dilutions of an Orion
Ca2 standard solution.
EC50 values for the CRC agonists were calculated using
Hill equation: Po  Po ini  ((Po max  Po ini)/(1  (EC50/
X)nH)), in which Po ini and Po max are the initial and maximal
Po values; X is concentration of drug; EC50 is X for one-half
maximal activation; nH is the Hill coefficient for the acti-
vation. EC50 value for the bell-shaped Ca
2 dependent
curve was calculated using the same Hill equation, in which
Po ini and Po max are the initial and maximal Po (Po at the
peak point of the Ca2 dependent curve) values. For IC50
value of the Ca2 dependent curve, we used the equation:
Po Po resi ((Po max Po res)/(1 (X/IC50)
nH)), in which
Po res and Po max are the residual and maximal Po (Po at the
peak point of the Ca2 dependent curve) values; IC50 is
Ca2 concentration for one-half maximal inhibition; nH is
the Hill coefficient for the inhibition. The graph fittings
were carried out using the “Origin” computer software.
Single channel data acquisition and analysis
Single channel currents were displayed on an oscilloscope
through a patch-clamp amplifier (Axopatch 200 B amplifi-
er), filtered at 1 kHz using a 4-pole low pass Bessel filter,
recorded with a 16-bit VCR-based acquisition and digital
tape recorder (Biologic DTR-1205), and digitized at 2 kHz
for analysis. Mean open probability (Po) of channels and the
lifetime of open and closed events were determined by 50%
threshold analysis using Axon Instruments software and
hardware (pClamp v6.0.3, Digidata 1200 AD/DA interface).
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Single channel Po was obtained from 120-s continuous
recordings. Lifetime analysis was carried out only when a
single channel was incorporated into the bilayer. Individual
life times were fitted to a probability density function by the
method of maximal likelihood according to the equation:
F(t)  	Pn 
 (1/n) 
 exp(t/n), in which Pn and n are
the relative areas of the distribution and time constants of
the nth state, respectively (pClamp6 v6.0.3, pSTAT).
[3H]ryanodine binding assay
Equilibrium ryanodine binding to SR was performed by
incubation of 0.05 mg of SR in 250 l of reaction mixture
containing 0.2 M KCl, 20 mM MOPS, 10 nM [3H]ryano-
dine, and 10 M-free Ca2 (pH 7.3) for 2 h at 37°C (Kim
et al., 1994). Caffeine- and/or quercetin-activated ryanodine
binding was measured in the presence of caffeine in various
concentrations with or without 10 M quercetin. One-hun-
dred microliters of polyethyleneglycol solution (30% poly-
ethyleneglycol, 1 mM EDTA, and 50 mM Tris, pH 7.3) was
added to each vial, and incubation was continued for 5 min
at room temperature. Precipitated protein was sedimented
for 5 min at 14,000 rpm in an Eppendorf microcentrifuge,
and the pellets were rinsed twice with 0.4 ml of the relevant
ryanodine binding buffer without radioactive ryanodine.
The pellets were then solubilized in 100 l of Soluene 350
(Packard) at 70°C for 30 min, and the solution was counted
in 4 ml of Picofluor (Packard) by liquid scintillation. For
nonspecific binding, a 100-fold amount of nonradioactive
ryanodine (Calbiochem) was included.
Statistical analysis
Results are given as mean  SE with the number of
experiments in parentheses. The mean  SE is included
within the figure symbol or indicated by error bars if it is
larger. Significance levels of the differences were ana-
lyzed by paired or unpaired t-test (GraphPad InStat, v
2.04). Differences were considered to be significant when
p  0.05.
RESULTS
Quercetin is a potent activator of CRC in the
presence of optimal cytosolic Ca2
The effect of quercetin on behavior of single CRC was
tested by the planar lipid bilayer method in the presence of
two different Ca2 concentrations (80 pM and 10 M) (Fig.
1), and compared with that of caffeine (Fig. 2), a well-
known CRC activating drug (Endo, 1977). At 80 pM cis
Ca2, the open probability (Po) of CRC increased gradually
with increasing cis quercetin concentration, however, no
apparent saturation was attained even at 0.7 mM quercetin
(Fig. 1 C). On the other hand, at 10 M Ca2, a much
higher maximal Po (0.89  0.01) was reached at 250 M
quercetin (EC50 91.0 15.3 M) (Fig. 1 C and Table 1).
In the presence of 10 M Ca2, the Hill coefficient (nH) for
activation of CRC was close to 1, suggesting that there is no
cooperative binding of quercetin on single CRC. The effects
of various quercetin concentrations on CRC were attained
within 10 s of stirring time, and there was no time-depen-
dent change of Po afterwards.
FIGURE 1 Single skeletal CRC activated by quercetin. Single channel
activity during the application of quercetin in the presence of 80 pM (A) or
10 M (B) free Ca2 was measured after incorporation into planar lipid
bilayer. Single channel currents shown as upward deflections from the
closed level (marked c), were recorded in symmetrical 1 M KCl, 10 mM
K-HEPES, pH 7.3 and 109 M CaCl2 plus 100 M EGTA (free [Ca
2] 
10 M) (B) or plus 125 mM EGTA (free [Ca2]  80 pM) (A). Quercetin
was added cumulatively to the cis side to obtain the indicated concentra-
tions (left panel). Current recordings were obtained at 30 mV. (C) Po
versus [quercetin] in the presence of 80 pM (F) or 10 M (E) Ca2. The
data are the mean  SE of five experiments.
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Millimolar concentrations of caffeine were
required for the maximal activation of the CRC
At 80 pM cis Ca2, the maximal Po (0.17  0.02) was
reached at 12 mM caffeine (EC50  9.38  0.72 mM),
whereas at 10 MCa2, a much higher maximal Po (0.66
0.01) was attained at9 mM caffeine (EC50 2.93 0.42
mM) (Fig. 2 C and Table 1). However, the maximal Po
attained at 10 M Ca2 was significantly less than that of
quercetin (0.66  0.01 vs. 0.89  0.01). These results
indicate that both drugs require an elevated Ca2 concen-
tration for full activation of CRC, and quercetin is a more
potent drug than caffeine for activation of CRC (Figs. 1 and
2). In the presence of 10 M Ca2, the Hill coefficient (nH)
for activation of CRC was close to 1, suggesting that there
is no cooperative binding of caffeine on single CRC. On the
other hand, at 80 pM Ca2, the nH value for activation of
CRC was close to 5. Thus, it appears that caffeine is bound
with a high cooperativity to CRC in the presence of very
low cytosolic Ca2 concentrations. However, relatively
high caffeine concentrations (5 mM) were required for
activation of CRC in the presence of 80 pM Ca2 (Fig. 2).
Similar results were previously obtained in sheep cardiac
CRC (Sitsapesan and Williams, 1990). It is important to
note that the highest amount of ethanol (1%) used for
solubilization of quercetin did not show a significant effect
on the recordings of CRC activities.
Characterization of behavior of single CRC
activated by quercetin and caffeine
When quercetin and caffeine were added together to the cis
side, time-dependent changes in CRC gating mode were
observed (Fig. 3 A). During the initial 2 min after the
addition of both drugs, the apparent gating mode (mode 1:
short openings with o  0.3–0.5 ms (80–90%)) was sim-
ilar to the one activated by quercetin or caffeine alone (Fig.
3 A and Table 2). As time passed (2 min), Po increased,
which appeared to be due to a change in the mode of
channel gating (Po  0.854  0.062, n  5) (Fig. 3 A and
Table 2; mode 2, longer openings with o  5 ms (50%)).
The period between mode 1 and mode 2 (intermode) was
short (10 s) and during the intermode period, both mode
1 and mode 2 appeared (data not shown). As we shall
describe below, mode 1 and mode 2 displayed clearly dis-
tinguishable gating properties.
To examine the nature of mode 2, serial treatments of the
two drugs were conducted. When 6 M quercetin and 3 mM
caffeine were added sequentially to the cis side at 5-min
intervals in the presence of 10 M Ca2, mode 2 appeared
and did not return intermittently to mode 1 (Fig. 3 B) (14
times in 15 trials, 93%). On the other hand, when first 3
mM caffeine and, then after 5 min, 6 M quercetin were
added, we observed no increase in Po within 25 min
before the spontaneous breakage of the lipid bilayer in 9 of
FIGURE 2 Single skeletal CRC activated by caffeine. Single channel
activity during the application of caffeine in the presence of 80 pM (A) or
10 M (B) Ca2 was measured after incorporation into planar lipid bilayer.
Single channel currents shown as upward deflections from the closed level
(marked c), were recorded in symmetrical 1 M KCl, 10 mM K-HEPES, pH
7.3 and 109 M CaCl2 plus 100 M EGTA (free [Ca
2]  10 M) (B) or
plus 125 mM EGTA (free [Ca2]  80 pM) (A). Caffeine was added
cumulatively to the cis side. Current recordings were obtained at 30 mV.
(C) Po versus [caffeine] in the presence of 80 pM (F) or 10 M (E) Ca
2.
The data are the mean  SE of five experiments.
TABLE 1 Ca2-dependent activation of single CRCs by
quercetin or caffeine
Drug [Ca2]free Maximal Po EC50
Quercetin 10 M 0.89  0.01* 91.0  15.3 M
Caffeine 10 M 0.66  0.01 2.93  0.42 mM
The experiments were carried out, as described in the legend to Fig. 1.
Values are the mean  SE for five experiments.
*Significantly different between caffeine and quercetin groups (unpaired
student t-test, p  0.05).
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11 experiments (Fig. 3 C). Two of the 11 experiments
showed a smaller increase in Po compared with that of mode
2 (the increment of Po was18% of the difference between
mode 1 and mode 2). Single CRC currents activated by 10
MCa2 were locked in a subconductance state by addition
of 10 M ryanodine to the cis side (data not shown).
Similarly, single CRC currents activated by 6 M quercetin
or 3 mM caffeine in the presence of 10 M Ca2 were also
locked in the subconductance state (data not shown). Ac-
cording to the I-V curves shown in Fig. 3 D, regardless of
the type of addition, 10 M ryanodine led to the formation
of a subconductance state (54%), indicating that drug
binding to the CRC did not interfere with the ryanodine-
induced conductance change. Additional treatments with 5
FIGURE 3 Single CRC activated by co-treatment, serial additions of quercetin and caffeine, or caffeine and quercetin. Activation of single CRC by 10
M Ca2, 3 mM caffeine, and 6 M quercetin (A), serial addition of 6 M quercetin and 3 mM caffeine (B) or 3 mM caffeine and 6 M quercetin (C),
and modification of the activities by 10 M ryanodine and 5 M ruthenium red were measured in the presence of 10 M of cis Ca2 by the planar lipid
bilayer method. (D) I-V curves for each experimental condition. Sub- and full-conductance states are represented by open and closed symbols, respectively.
The symbols are: 10 MCa2 (E, F), 10 MCa2 and 6 M quercetin (‚, Œ), 10 MCa2 and 3 mM caffeine (, f), and 10 MCa2 and co-treatment
(, ).
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M ruthenium red led to complete channel closing in all
three cases (Fig. 3, A–C, n  5).
To examine whether the high Po shown in mode 2 was
due to an irreversible modification of CRC, we first re-
moved quercetin by perfusion of the cis chamber with a
solution containing 3 mM caffeine, followed by removal of
caffeine using a caffeine-free perfusion solution (Fig. 4 A,
n  3). Po was reduced from 0.898  0.083 to 0.327 
0.055 (which was not significantly different from that of 3
mM caffeine in the presence of 10 M Ca2) after removal
of quercetin, and to 0.192  0.011 (which was not signif-
icantly different from that of 10 M Ca2) after further
removal of caffeine (Fig. 4 A). In addition, sequential re-
moval of both drugs in reverse order (caffeine first and
quercetin second), showed similar results (Fig. 4 B, n  3).
According to the open-time and closed-time constants de-
termined below (Table 2), overall patterns of their gating
modes were also regained in each step by the sequential
perfusions of both drugs. These results suggest that under
the experimental conditions of this study, the appearance of
mode 2 was not due to an irreversible modification of CRC.
Analyses of Po and lifetime of single CRC
activated by quercetin, caffeine, or both
To obtain a clearer picture of the single channel events
leading to the appearance of mode 2, we analyzed the
effects of caffeine, quercetin, or both on Po and the lifetimes
of single CRCs (Table 2). Addition of 6 M quercetin or 3
mM caffeine in the presence of 10 M Ca2 changed the
number of open events per second from 525  59 to 704 
91 or from 571  88 to 844  108. The major mean
open-time (o1) and closed-time (c2) constants in the pres-
ence of quercetin were 0.520  0.012 ms (91.2  4.3%)
and 1.257  0.201 ms (75.6  3.5%), respectively. How-
ever, the major respective o1 and c1 in the presence of
caffeine were 0.302 0.032 ms (79.9 3.1%) and 0.435
0.055 ms (95.6  4.7%), which are significantly different
from those of quercetin. It is important to note that 6 M
quercetin (only 7% of EC50) leads to a larger open time
constant than 3 mM caffeine (EC50). These data indicate
that the two drugs activated the CRC differently, even
though their Po values were not significantly different
(quercetin, 0.316  0.032; caffeine, 0.312  0.021) (Table
2). Co-treatment of caffeine and quercetin changed the
number of open events per second from 551  71 to 790 
121 in mode 1. However, a switch from mode 1 to mode 2
decreased significantly the number of open events per sec-
ond from 790  121 to 134  137, which was due to the
formation of long open events (o2  5.432  0.261 ms,
46.3  12.1% and c1  0.316  0.020 ms, 90.7  8.9%))
(Table 2, mode 2).
Fig. 1 and Table 2 show that in the presence of 10 M
Ca2, 0.3 mM quercetin led to an almost maximal Po
TABLE 2 Mean open and closed times of single CRCs in various experimental conditions
Types of Experiment po
Open Events,
(S1)
Open Closed
o (ms) Proportion (%) c (ms) Proportion (%)
10 M Ca2 (26) 0.174  0.069 580  103 0.292  0.064 92.1 3.8 0.701  0.088 80.9  3.4
1.817  0.098 7.9  3.8 8.420  0.201 19.1  3.4
10 M Ca2  6 M quercetin 0.316  0.032* 704  91 0.520  0.012 91.2  4.3 0.354  0.032 24.4  3.5
(5) 2.679  0.045 8.8  4.3 1.257  0.201 75.6  3.5
10 M Ca2  3 mM caffeine 0.312  0.021* 844  108 0.302  0.032† 79.9  3.1 0.435  0.055 95.6  4.7†
(5) 1.886  0.131† 20.1  3.1 5.827  0.131† 4.4  4.7†
10 M Ca2  co-treatment (5)
Mode 1 0.376  0.043* 790  121* 0.478  0.045 91.3 8.1 0.679  0.042 87.5  7.3
2.187  0.212 8.7  8.1 2.589  0.119 12.5  7.3
Mode 2 0.854  0.062** 134  137** 0.745  0.019** 53.7 12.1** 0.316  0.020** 90.7  8.9
5.432  0.261** 46.3 12.1** 2.499  0.107 9.3  8.9
10 M Ca2  0.3 mM 0.826  0.049 951  109‡ 1.343  0.067‡ 22.1  11.4‡ 0.537  0.046‡ 89.3  8.9
quercetin (5) 2.579  0.241‡ 77.9  11.4‡ 2.427  0.114 10.7  8.9
{10 M Ca2  both drugs}  0.327  0.055 863  188 0.320  0.044 89.2 3.7 0.504  0.052 79.4  4.8
quercetin (3) 1.690  0.112 10.8  3.7 4.470 0.132 20.6  4.8
{10 M Ca2  both drugs}  0.332  0.054 785  101 0.491  0.035 89.0 6.9 0.304  0.079 39.3  10.1
caffeine (3) 2.993  0.061 11.0  6.9 1.099 0.081 60.7  10.1
Values are the means  SE for N number of channels shown in parenthesis. Each drug experiment was paired with 10 M Ca2 and the paired data of
10 M Ca2 were used for paired student t-test. The overall combined data for 10 M Ca2 are shown in the table for reference.
*Significantly different between 10 M Ca2 and 10 M Ca2  6 M quercetin, 10 M Ca2  3 mM caffeine or 10 M Ca2  co-treatment for
Po (paired t-test, p  0.05).
**Significantly different between mode 1 and mode 2 for Po, open events, mean open-time, and closed-time constants (paired t-test, p  0.05).
†Significantly different between 10 MCa2  6 M quercetin and 10 MCa2  3 mM caffeine for mean open-time and closed-time constants (unpaired
t-test, p  0.05).
‡Significantly different between 10 M Ca2  co-treatment (mode 2) and 10 M Ca2  0.3 mM quercetin for open events, mean open-time, and
closed-time constants (unpaired t-test, p  0.05).
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(0.826  0.049) that was not significantly different from
that of mode 2 (0.854  0.062). However, the major open
times for the two conditions were significantly different (0.3
mM quercetin: o2  2.579  0.241 ms, 77.9  11.4% vs.
mode 2: o2  5.432  0.261 ms, 46.3  12.1%), suggest-
ing that the mechanism for the apparent maximal activation
of single CRCs by quercetin plus caffeine is different from
that by quercetin alone.
Quercetin and caffeine affect Ca2 dependence
of CRC differently
Fig. 5 compares the Ca2-dependence of CRC activity in
the absence and presence of quercetin or caffeine. Fig. 5, A
and D show the typical bell-shaped Ca2-dependence of
channel activity (Kim et al., 1983; Meissner et al., 1986).
When 10 M quercetin was added to the cis side, Po
increased at the ascending phase of the Ca2 activation/
inactivation curve but was without effect on the descending
phase (Fig. 5, B and D). The maximal Po value increased
significantly (0.386  0.020 to 0.510  0.011, n  5),
however, the [Ca2] concentration required to obtain the
maximal Po (Fig. 5 D) did not change significantly. Table 3
shows that [Ca2] for one-half maximal activation (EC50)
and one-half maximal inhibition (IC50) of CRC were not
significantly altered by quercetin.
On the other hand, when 3 mM caffeine was added to the
cis side, Po increased at both the ascending and descending
phases (Fig. 5, C and D). Caffeine did not change signifi-
cantly the [Ca2] required to obtain the maximal Po value
(Fig. 5 D). Table 3 shows that caffeine did not significantly
change EC50 for Ca
2, but increased the IC50 for Ca
2
significantly (530  73 vs. 186  34 M, n  5). These
results suggest that the low affinity Ca2 binding site(s) of
CRC is affected by caffeine but not by quercetin.
[3H]Ryanodine binding in the presence of caffeine
and quercetin
The mechanisms of CRC activation by quercetin and caf-
feine were also assessed by [3H]ryanodine binding, using
rabbit skeletal SR in the presence of 10 M Ca2 and
various concentrations of caffeine with (open circle) or
without (filled circle) 10 M quercetin (Fig. 6). Caffeine
and quercetin were added at the same time, duplicating the
conditions of Fig. 3 A. Caffeine increased [3H]ryanodine
binding, yielding a Bmax value of 6.62  0.01 pmol/mg SR
protein (n  5). In the presence of 10 M quercetin,
caffeine increased [3H]ryanodine binding additionally to a
maximal value (8.64  0.08, n  5) without a change in
EC50 (Table 4). These results indicate that the effects of the
two drugs are additive.
FIGURE 4 Effects of sequential removal of quercetin and caffeine (A) or
caffeine and quercetin (B) after co-treatment of both drugs on CRC activity
by perfusion of cis solutions. Po of each state is given on the left side.
Single channel currents shown as upward deflections from the closed level
(marked c) were recorded in symmetrical 1 M KCl, 10 mM K-HEPES, pH
7.3, and 10 M cis Ca2 (top trace), 30 s (second trace), and 3 min (third
trace) after the addition of 3 mM caffeine and 6 M quercetin, and after
sequential removal of quercetin and caffeine (A) or caffeine and quercetin
(B) by perfusion (fourth and fifth trace). Current recordings were obtained
at 30 mV. The data are the mean  SE of three experiments.
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FIGURE 5 Ca2-dependence of single CRC activity in the presence of quercetin or caffeine. Recordings were made at various [Ca2] alone (A, control) or in
the presence 10 M quercetin (B) and 3 mM caffeine (C). (D) The plots of Po versus [Ca
2] in the absence (f, control) or presence of 10 M quercetin (F) and
3 mM caffeine (Œ). Single channel currents shown as upward deflections from the closed level (marked c) were recorded in symmetrical 1 M KCl and 10 mM
K-HEPES, pH 7.3 at indicated [Ca2]. Current recordings were obtained at 30 mV. The values are the mean  SE of five independent experiments.
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Effects of quercetin on single CRC in the
presence of glutathione
Glutathione, a low molecular weight peptide, sets the redox
potential in cells (Deneke and Fanburg, 1989). To examine
whether the effects of quercetin on CRC shown above were
related to redox states, partially Ca2-activated CRCs (1
M cis Ca2) were exposed to glutathione. In agreement
with a previous report (Zable et al., 1997), addition of 5 mM
cis GSSG, an oxidized form of glutathione, increased Po
from 0.072  0.012 to 0.171  0.022 (n  3) (Fig. 7 A).
Subsequent addition of 0.3 mM quercetin further increased
the Po to 0.795  0.065 (n  3). This Po value was similar
to that measured for Ca2 and quercetin-activated channels
not pretreated with 5 mMGSSG (Po, 0.782 0.061, n 3).
When 5 mM GSH, a reduced form of glutathion, was added
to the activated channel, the Po did not change significantly
(0.784  0.073, n  3). The results suggest that the mech-
anisms for quercetin activation of CRC are likely not di-
rectly related to the redox states of CRC.
FIGURE 6 [3H]ryanodine binding as function of caffeine concentration
in the presence or absence of quercetin. Equilibrium ryanodine binding to
SR was performed, as described in Materials and Methods, in 250 l of a
reaction mixture containing 0.2 M KCl, 20 mM MOPS (pH 7.3), 10 nM
[3H]ryanodine, 10 M free Ca2, 0 (F) or 10 M quercetin (E), and the
indicated concentrations of caffeine for 2 h at 37°C. The values are the
mean  SE of five independent experiments.
FIGURE 7 Modulation of quercetin-activated single CRC by glutathione
or ATP. CRC activated at 1 M Ca2 was recorded following the sequen-
tial addition of 5 mM GSSG, 0.3 mM quercetin, and 5 mM GSH (A) or 5
mM ATP and 0.3 mM quercetin (B). Single channel currents shown as
upward deflections from the closed level (marked c) were recorded in
symmetrical 1 M KCl and 10 mM K-HEPES, pH 7.3. Current recordings
were obtained at 30 mV. Po are given on the right side. The values are
the mean  SE of three independent experiments.
TABLE 4 Effects of caffeine on [3H]ryanodine binding in the
absence and presence of quercetin
Assay Medium
Bmax,
pmol/mg
Protein EC50, mM
10 M Ca2 6.62  0.01 1.24 0.01
10 M Ca2  10 M quercetin 8.64  0.08* 1.38 0.08
The experiments were carried out, as described in Fig. 6. Values are the
mean  SE of five experiments.
*Significantly different between 10 M Ca2 and 10 M Ca2  10 M
quercetin groups (unpaired student t-test, p  0.05).
TABLE 3 Ca2 concentrations for one-half maximal
activation (EC50) and one-half maximal inhibition (IC50) of Po in
the absence or presence of quercetin and caffeine
Addition EC50 (M) IC50 (M)
10 M Ca2 5.31  1.81 186 34
10 M Ca2  10 M quercetin 3.29  1.26 158 29
10 M Ca2  3 mM caffeine 3.17  1.05 530 73*
Values are the mean  SE of five experiments.
*Significantly different between 10 M Ca2 and 10 M Ca2  10 M
quercetin or 10 M Ca2  3 mM caffeine groups (unpaired student t-test,
p  0.05).
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The hypothesis that quercetin shares the same binding
site(s) on CRC with ATP was tested in Fig. 7 B. Partially
Ca2-activated single CRCs were first activated by 5 mM
K-ATP (Po, 0.228  0.024, n  3) (Fig. 7 B). The subse-
quent addition of 0.3 mM quercetin led to a further increase
of Po to 0.561  0.054 (n  3). However, this value was
significantly lower than the one measured for channels
recorded in the presence of 1 M Ca2 and 0.3 mM
quercetin but absence of ATP (Po, 0.782  0.061, n  3).
Thus, it appears that ATP can partially inhibit the action of
quercetin on the CRC. This result could be explained if ATP
and quercetin share a binding site on the CRC. Alterna-
tively, ATP binding could allosterically influence the ef-
fects of quercetin. More extensive biochemical and bio-
physical studies will be required to elucidate the
relationship of the action of ATP and quercetin on CRC
activity.
DISCUSSION
Quercetin, a bioflavonoid, is known to increase Ca2 re-
lease from SR (Kirino and Shimizu, 1982; Watras et al.,
1983; Kim et al., 1983; Palade et al., 1983). Increased Ca2
release by quercetin could be associated with its inhibitory
effect on the Ca2 ATPase (Shoshan and MacLennan, 1981;
Shoshan et al., 1980) as well as its stimulatory effect on
CRC (Kim et al., 1983). However, a direct effect of quer-
cetin on CRC was not established in earlier work. In the
present study, the effect of quercetin on CRC was examined
at single channel level and compared with that of caffeine,
a well-characterized CRC agonist (Endo, 1977).
Although the CRC was activated by both quercetin and
caffeine, there were some remarkable differences. Differ-
ences in the effects of the two drugs included: 1) quercetin
was a considerably stronger agonist than caffeine in terms
of EC50 (32
) and higher maximal Po (0.89  0.01 vs.
0.66  0.01) of the dose response curve (Figs. 1 and 2); 2)
gating mode of the CRC activated by quercetin was differ-
ent from that by caffeine (Table 2); 3) sequential addition of
quercetin and caffeine, but not caffeine and quercetin, in-
duced time-dependent changes in CRC gating behavior
(Fig. 3); 4) quercetin affected only the ascending phase of
the Ca2 activation/inactivation curve, whereas caffeine
affected both the ascending and descending phase (Fig. 5).
These results indicate that quercetin and caffeine are CRC
agonists that may have different activation mechanisms, due
presumably to different binding sites on CRC or to inducing
different conformational changes.
Characterization of single CRC behavior affected
by quercetin or caffeine
The apparent affinity of CRC for both quercetin (Fig. 1) and
caffeine (Fig. 2) considerably increased by elevating [Ca2]
from 80 pM to 10 M (EC50  91.0  15.3 M in the
presence of quercetin and 2.93  0.42 mM in the presence
of caffeine, both at 10 M Ca2 (Table 1). The result
suggests that a conformational change of CRC upon binding
of Ca2 to its high affinity binding site could lead to an
increased drug binding affinity. Similar results for caffeine
were reported previously (Endo et al., 1977; Kim et al.,
1983; Rousseau et al., 1988; Rousseau and Meissner, 1989;
Meissner et al., 1997). The effective concentration for the
activation of CRC by quercetin was 32 times lower than
for caffeine (Figs. 1 and 2). The different drug efficacy for
activation of CRC is not likely due to lipid solubility of the
drugs, because the caffeine-binding site is present on the
cytosolic side (Meissner, 1994). An analysis of Po and the
gating mode of single CRC showed that the mean open-
time and closed-time constants (o and c) and their
proportions were significantly different for the caffeine-
and quercetin-activated CRCs, even though Po values
were similar (Table 2).
Ryanodine binding to its high-affinity site(s) stabilizes
the open state of CRC, however, open channel conductance
is subnormal (Rousseau et al., 1987; Carroll et al., 1991;
Pessah and Zimanyi, 1991; Buck et al., 1992). The I-V
relations in Fig. 3 D show that the conductances and levels
of subconductance state formed by 10 M ryanodine were
similar in all cases (Fig. 3), suggesting that quercetin does
not modify the ion selectivity of the CRC.
Time-dependent synergistic effect of quercetin
and caffeine on single CRC
The simultaneous addition of caffeine and a relatively low
concentration of quercetin (6 M) to the cis side of the
bilayer induced time-dependent changes in CRC gating
(Fig. 3). Two modes (mode 1 and mode 2) having clearly
distinguishable gating behaviors were seen (Fig. 3). Mode 2
required the presence of both drugs and had a significantly
higher Po than mode 1 (0.854  0.062 vs. 0.376  0.043).
This high Po was not a simple summation of the effects of
caffeine and quercetin, suggesting that their effects on CRC
are synergistic. [3H]ryanodine binding (Fig. 6) also suggests
that caffeine and quercetin have additive effects on CRC
activity. On the other hand, remarkably, the initial addition
of caffeine to single CRC rendered the channels insensitive
to subsequent modification by quercetin. We propose that
caffeine induces conformational changes that perhaps
may result in the occlusion of a site for quercetin binding
(Fig. 3).
Fig. 4 shows that the sequential removal of quercetin and
caffeine or caffeine and quercetin reduced Po close to the
levels measured before the addition of the drugs. This result
suggests that the effects of quercetin and caffeine on single
CRC are reversible and are not due to an irreversible mod-
ification of CRC. Single channel data obtained in the pres-
ence of oxidized/reduced glutathione suggest that the effects
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of quercetin were largely independent on CRC redox state.
It is also important to note that channel activation by high
quercetin concentration (Fig. 1 and Table 2) was fast (10
s) and therefore appeared to occur by a mechanism different
from that in the presence of caffeine and 6 M quercetin.
Quercetin and caffeine showed clearly
distinguishable effects on Ca2 concentration-
dependence of CRC activation
The mechanisms of quercetin and caffeine action were
further studied by examining their effects on the bell-shaped
CRC Ca2-activation/inactivation curve (Fig. 5). Both quer-
cetin and caffeine increased Po of the ascending phase of the
Ca2-activation/inactivation curve (Fig. 5), whereas only
caffeine increased Po of the descending phase (Fig. 5 D).
The IC50 of Ca
2 in the presence of caffeine was signifi-
cantly higher than the control (530  73 M vs. 186  34
M) (Table 3), indicating that more Ca2 is required for the
same degree of inhibition, if caffeine is present. On the
other hand, it appears that when the low affinity Ca2
binding site(s) is (are) occupied by Ca2, quercetin was
without effect (Fig. 5).
CRCs have been reported to switch between different
modes of activity: an inactivated mode with no channel
openings, a low-activity mode with single channel open-
ings, and a high activity mode with bursts of openings
(Zahradnikova and Zahradnik, 1995; Armisen et al., 1996).
This study shows that the combined presence of quercetin
and caffeine transforms the skeletal muscle CRC from a low
to a high activity mode. Pharmacological stabilization of the
high-activity mode should help studies aimed at a better
understanding of the modal gating behavior of the CRCs.
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